Myriad Genetics, Inc. (MYGN)
Bank of America Merrill Lynch Health Care Conference Call
May 16, 2012 7:20 pm ET
ExecutivesPeter D. Meldrum – President, Chief Executive Officer and DirectorAnalystsDerik de Bruin – Bank of America Merrill LynchPresentation
Derik de Bruin – Bank of America Merrill Lynch
Previous Statements by MYGN
» Myriad Genetics' CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Myriad Genetics' CEO Discusses F2Q12 Results - Earnings Call Transcript
» Myriad Genetics' CEO Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript)
Thank you, Derik, and welcome to Myriad Genetics presentation. I will point out that I may be making some forward-looking statements, so please consult our Securities Filings, in particular the 10-Q and 10-K and 8-K reports.Myriad Genetics is a leading molecular diagnostic company focused on the development and discovery of transformative products that benefit patients and stays alive. These tests are involved in affecting an individual’s risk of developing cancer and other major diseases later in life, products that guide treatment decisions so that the patient can get the right drug at the right time, and with the right dose and assessing risk of progression, so that we don’t over treat patients, but can aggressively treat those patients who have a more aggressive form of disease.Myriad has a very broad portfolio of products, nine innovative tests that the company has launched and are commercially selling. And that’s backed up by a very strong product pipeline. The thirteen industry-leading under tests under development across multiple disease indication.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV